While I can't share personal experiences, I can provide information about CAR-T cell therapy for multiple myeloma based on the context provided:

- Procedure Overview
- T Cell Collection: T cells are collected from your blood through a process called apheresis.
- Genetic Modification: These T cells are genetically Show Full Answer

While I can't share personal experiences, I can provide information about CAR-T cell therapy for multiple myeloma based on the context provided:

- Procedure Overview:
- T Cell Collection: T cells are collected from your blood through a process called apheresis.
- Genetic Modification: These T cells are genetically engineered in a lab to produce chimeric antigen receptors (CARs) that help them target and kill myeloma cells.
- Infusion: The modified T cells are then infused back into your body.

- Preparation:
- Lymphodepletion: Before receiving the CAR-T cells, you may undergo a round of chemotherapy to make room for the new T cells.

- Side Effects:
- Common: Infections, muscle aches, diarrhea, nausea, swelling, fever, cough, headache, and loss of appetite.
- Serious: Cytokine release syndrome (CRS), which can be life-threatening and cause neurological side effects like seizures, hallucinations, and tremors.

- Effectiveness:
- CAR-T cell therapy has shown promising results, with some patients experiencing a complete or partial reduction in tumor burden.

If you're considering CAR-T cell therapy, it's important to discuss the risks and benefits with your doctor.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Myeloma Treatments: Risks and Benefits | MyMyelomaTeam